photomicrograph of a diffuse large B-cell lymphoma (DLBCL) a type of non-Hodgkin lymphoma, Cell image, pink and purple colours

Advances in Lymphoma

Transcript: Key lymphoma takeaways from ESMO 2024

Last updated: 30th Sep 2024

Published: 30th Sep 2024

Declaration of sponsorship: Takeda Pharmaceuticals U.S.A. Inc.

Professor Andrés Ferreri

All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.

This is a fantastic congress where the several presentations that regards, in particular, the new technologies, new pharmacology, and the inclusion of artificial intelligence in the development of the protocols and the studies. I think that these new strategies will be used not only for the solid tumour, but also in oncohematology, and then they will be applied to lymphoma patients in brief.

View the video

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information

Name

Email address

Specialty

By providing your email address, you are opting in to receive our monthly newsletter.

Opt-in: By selecting this box, I consent to receiving marketing communications and information about Medthority's resources by email.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event